Novartis profit slips as key drug goes generic
October 25, 2016 at 04:02 AM EDT
Swiss drug company Novartis saw net profit slip in the third quarter as the loss of a key drug to generic use in the United States outweighed strong sales of its psoriasis drug Cosentyx and MS treatment Gilenya.
